New analyses show DLB patients with lower plasma pTau181 levels — indicating an earlier stage of disease and absence of Alzheimer’s disease (AD) co-pathology — experienced greater clinical benefit wit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results